Marksans Pharma Limited (MARKSANS.NS)

INR 314.2

(-1.83%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 26.8 Billion 21.9 Billion 16.4 Billion 12.28 Billion 8.96 Billion 8.03 Billion
Total Current Assets 18.62 Billion 16.75 Billion 12.01 Billion 9.02 Billion 5.9 Billion 5.31 Billion
Cash And Short Term Investments 7 Billion 7.19 Billion 3.46 Billion 2.09 Billion 931.2 Million 328.54 Million
Cash and Cash Equivalents 6.73 Billion 3.82 Billion 3.46 Billion 2.09 Billion 931.2 Million 328.54 Million
Short Term Investments 269.94 Million 3.36 Billion 4.35 Million 17.23 Million - -
Net Receivables 4.53 Billion 4.18 Billion 4.11 Billion 2.76 Billion 2.43 Billion 1.84 Billion
Inventory 6.17 Billion 4.84 Billion 4.24 Billion 4.04 Billion 2.41 Billion 2.93 Billion
Other Current Assets 908 Million 526.43 Million 185.05 Million 118.24 Million 112.64 Million 209.42 Million
Total Non-Current Assets 8.18 Billion 5.15 Billion 4.38 Billion 3.25 Billion 3.06 Billion 2.72 Billion
Net PPE 6.81 Billion 3.86 Billion 3.42 Billion 2.54 Billion 2.2 Billion 1.98 Billion
Good Will And Intangible Assets 1.04 Billion 1.09 Billion 885.94 Million 670.21 Million 826.39 Million 716.44 Million
Good Will 394.99 Million 384.89 Million 300.25 Million 195.86 Million 243.75 Million 314.49 Million
Intangible Assets 647.62 Million 707.97 Million 585.69 Million 474.35 Million 582.63 Million 401.94 Million
Long-Term Investments 26.19 Million -3.33 Billion -62.03 Million 8.4 Million 3.06 Billion -
Tax Assets 647.62 Million 3.37 Billion 38.57 Million 7.98 Million 6.34 Million 12.48 Million
Other Non Current Assets -342.72 Million 145.66 Million 103.65 Million 33.18 Million -3.02 Billion 12.91 Million
Other Assets - - - - - -
Total Liabilities 5.95 Billion 4.25 Billion 4.17 Billion 3.22 Billion 2.47 Billion 2.51 Billion
Total Current Liabilities 3.89 Billion 3.4 Billion 3.56 Billion 2.98 Billion 2.19 Billion 2.32 Billion
Account Payables 2.68 Billion 2.3 Billion 2 Billion 1.68 Billion 1.04 Billion 1.06 Billion
Tax Payables 199.08 Million 252.78 Million 173.27 Million 300.21 Million 118.57 Million 49.04 Million
Short Term Debt 540.42 Million 572.56 Million 693.44 Million 247.76 Million 188.88 Million 1 Billion
Deferred Revenue 199.08 Million 418.95 Million 324.98 Million 410.25 Million 482.22 Million 130.78 Million
Other Current Liabilities 476.22 Million 112.38 Million 542.97 Million 639.33 Million 480.74 Million 132.6 Million
Total Non Current Liabilities 2.05 Billion 843.27 Million 609.11 Million 244.99 Million 280.29 Million 183.85 Million
Long-Term Debt 1.9 Billion 656.89 Million 414.34 Million 93.25 Million 107.61 Million 100 Million
Deferred Revenue Non Current - - - 121.1 Million 114.74 Million -100 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 45.59 Million 32.52 Million 18.56 Million -50 Million -50 Million 113.55 Million
Other Liabilities - - - - - -
Total Equity 20.85 Billion 17.65 Billion 12.22 Billion 9.05 Billion 6.49 Billion 5.52 Billion
Stock Holders Equity 20.65 Billion 17.45 Billion 12.02 Billion 8.86 Billion 6.36 Billion 5.42 Billion
Common Stock 453.16 Million 453.16 Million 409.31 Million 409.31 Million 409.31 Million 409.31 Million
Retained Earnings 10.68 Billion 10.91 Billion 5.09 Billion 3.34 Billion 851.09 Million 29.78 Million
Accumulated other comprehensive income 20.19 Billion 4.17 Billion 4.78 Billion 3.35 Billion -1.33 Billion -1.14 Billion
Common Stock Equity 20.65 Billion 17.45 Billion 12.02 Billion 8.86 Billion 6.36 Billion 5.42 Billion
Capital Lease Obligation 1.9 Billion 813.57 Million 694.86 Million 153.62 Million 107.61 Million -
Total Investments 296.13 Million 34.77 Million 26.08 Million 25.63 Million 3.06 Billion -
Total Debt 2.44 Billion 1.22 Billion 1.1 Billion 341.02 Million 296.49 Million 1 Billion
Net Debt -4.29 Billion -2.59 Billion -2.35 Billion -1.75 Billion -634.7 Million 673.61 Million

Balance Sheet Charts